116 related articles for article (PubMed ID: 15604066)
1. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
Wan X; Huang HH; Li JG
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1391-4. PubMed ID: 15604066
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
4. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
Wu W; Ding HL; Chen LH; Fu ZZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1742-4. PubMed ID: 17259110
[TBL] [Abstract][Full Text] [Related]
5. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
7. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats].
Duan HJ; Liu SX; Zhang YJ; Liu QJ; He N; Li YM
Yao Xue Xue Bao; 2004 Jul; 39(7):481-5. PubMed ID: 15493832
[TBL] [Abstract][Full Text] [Related]
8. Effect of losartan on the mRNA expressions of MT3-MMP and TIMP-2 in diabetic kidneys.
Ding HL; Xu MT; Guo Y; Chen L; Zhang SL; Li F; Fu ZZ
Rev Diabet Stud; 2005; 2(4):216-20. PubMed ID: 17491697
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
[TBL] [Abstract][Full Text] [Related]
10. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
11. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy].
Xu JY; Tao LJ; Wang L; Ning WB; Liu JS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):836-40. PubMed ID: 18812664
[TBL] [Abstract][Full Text] [Related]
12. [Effects of captopril and losartan on expression of kidney aquaporin-2 mRNA and urine aquaporin-2 excretion in rats].
Jiang RY; Xu DL; Lai WY; Ren H; Shen QB; Shao YH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):391-4. PubMed ID: 15837635
[TBL] [Abstract][Full Text] [Related]
13. Losartan inhibited expression of matrix metalloproteinases in rat atherosclerotic lesions and angiotensin II-stimulated macrophages.
Liang C; Wu ZG; Ding J; Jiang JF; Huang GZ; Du RZ; Ge JB
Acta Pharmacol Sin; 2004 Nov; 25(11):1426-32. PubMed ID: 15525463
[TBL] [Abstract][Full Text] [Related]
14. [The effect of inhibiting nuclear factor-kappa B on the diabetic nephropathy].
Ding H; Li F; Xu M; Deng Y; Deng Q; Zhu Z; Cheng H; Fu Z; Wang Y
Zhonghua Nei Ke Za Zhi; 2002 Sep; 41(9):605-9. PubMed ID: 12421493
[TBL] [Abstract][Full Text] [Related]
15. [Effects of losartan on expressions of plasminogen activator and plasminogen activator inhibitor-1 of rat proximal tubular epithelial cells cultured with high glucose].
Pu LJ; Huang SM; Liu F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):813-5. PubMed ID: 17953365
[TBL] [Abstract][Full Text] [Related]
16. [Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions].
Wang XM; Zhou TF; Liu B; Wei L; Shi K; Zhao SS; Hua YM; Liu HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):255-9. PubMed ID: 19462901
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
Yao XM; Ye SD; Chen Y; Zai ZM; Li XC; Wang YX; Chen K
Diabetes Obes Metab; 2009 May; 11(5):519-22. PubMed ID: 19236438
[TBL] [Abstract][Full Text] [Related]
18. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
19. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
Dong FQ; Li H; Cai WM; Tao J; Li Q; Ruan Y; Zheng FP; Zhang Z
Chin Med J (Engl); 2004 Jul; 117(7):1040-4. PubMed ID: 15265379
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
